P626: A PHASE 1 STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF BCL-2 INHIBITOR BGB-11417 IN ADULT PATIENTS WITH MATURE B-CELL MALIGNANCIES

Authors: Caixia LI, Jia Wei, Liu Peng, He Huang, Fei LI, Yujun Dong, Qingqing Cai, Shenmiao Yang, Xinyou Zhang, Hui Zhou, Lu Zhang, Zaixing Shi, Zhiyu Liang, Binghao Wu, Keshu Zhou, Depei Wu

Published: 2023-08-21

DOI: 10.1097/01.hs9.0000969408.27108.10

Source: Full article

---

Abstract

No abstract found.